TRPV3 antagonists (Pfizer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTRPV3 antagonists (Pfizer)
Drug Alias NameTRPV3 antagonists (Hydra)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 3 channel antagonists
TargetsTransient receptor potential cation channel subfamily V member 3
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHydra Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHydra BiosciencesPfizer Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A